Hudecz F
Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Budapest, Hungary.
Biomed Pept Proteins Nucleic Acids. 1995;1(4):213-20.
In order to elucidate structural and biological properties required for an optimal immunological carrier function and to provide a rational basis for its selection, two new groups of synthetic branched polypeptides with a general formula poly[Lys-(X(i)-DL-Ala(m))][XAK] or poly[Lys-(DL-Ala(m)-X(i))][AXK], where m approximately 3 and i < 1 were introduced by our laboratory. Here we review our recent results on the application of these polypeptides as biodegradable carriers for constructing synthetic immunogens/antigens with a well-known phenyl oxazolone hapten, peptide epitopes of epithelial mucin [MUCI] or herpes simplex virus [HSV 1] glycoprotein D. Observations collected during the last five years with the conjugates presented serve to illustrate the usefulness of branched polypeptides as carriers for the rational design of synthetic immunogens for the development of vaccines or clinically relevant immunodiagnostics. Furthermore, this polypeptide model system enables the analysis and potentially reliable interpretation of the correlation between chemical structure and immunogenic/antigenic features.
为了阐明最佳免疫载体功能所需的结构和生物学特性,并为其选择提供合理依据,我们实验室引入了两组新的合成支链多肽,其通式为聚[赖氨酸-(X(i)-DL-丙氨酸(m))][XAK]或聚[赖氨酸-(DL-丙氨酸(m)-X(i))][AXK],其中m约为3且i < 1。在此,我们回顾了我们最近关于这些多肽作为可生物降解载体的应用结果,这些载体用于构建具有著名的苯恶唑酮半抗原、上皮粘蛋白[MUCI]的肽表位或单纯疱疹病毒[HSV 1]糖蛋白D的合成免疫原/抗原。在过去五年中对所呈现的缀合物进行的观察结果表明,支链多肽作为载体对于合理设计用于疫苗开发或临床相关免疫诊断的合成免疫原是有用的。此外,这个多肽模型系统能够分析并潜在可靠地解释化学结构与免疫原性/抗原性特征之间的相关性。